Last reviewed · How we verify
NCT07040332
Pathogenesis and Inflammatory Phenotype of Allergic Bronchopulmonary Aspergillosis
trial in Allergic Bronchopulmonary Aspergillosis (ABPA) in 140 participants. Currently enrolling.
31 July 2027
Quick facts
| Lead sponsor | Qianfoshan Hospital |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 140 |
| Start date | 10 May 2025 |
| Primary completion | 31 July 2027 |
| Estimated completion | 31 January 2029 |
| Sites | 1 location across China |
Conditions studied
- Allergic Bronchopulmonary Aspergillosis (ABPA) — all drugs for Allergic Bronchopulmonary Aspergillosis (ABPA) →
Sponsor
Qianfoshan Hospital
Who can join
18 and older, any sex, with Allergic Bronchopulmonary Aspergillosis (ABPA). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to reveal the immune and inflammatory regulatory molecular mechanisms related to the progression of allergic bronchopulmonary aspergillosis (ABPA), and to build a precision typing based on inflammation and identify the biomarkers of typing, and to explore the clinical outcomes of different inflammatory phenotypes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07040332
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Allergic Bronchopulmonary Aspergillosis (ABPA)
Currently open trials in the same condition.
- NCT07362667 — A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA · recruiting
- NCT07493629 — Immune Status and Disease Control of Inflammatory Airway Diseases · recruiting
- NCT07362693 — A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA · recruiting
Other Qianfoshan Hospital trials
Trials by the same sponsor.
- NCT05727618 — The Effect of Pituitrin on the Patients With Pulmonary Hypertension Undergoing Cardiac Surgery · NA · suspended
- NCT06837831 — Mepilex Lite Dressings for the Treatment of Acute Radiation Dermatitis of Anal Canal Skin · NA · recruiting
- NCT07260760 — Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke · not yet recruiting
- NCT07362667 — A Study of the Efficacy and Safety of Bronchoscopic Airway Clearance and Amphotericin B Spraying in Patients With ABPA · recruiting
- NCT07271849 — Nalbuphine Timing Effects on Hemodynamics and Analgesia in Elderly Patients · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07040332 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Qianfoshan Hospital
- Last refreshed: 4 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07040332.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing